Kandimalla E[au] - Search Results

Year	Number of Results
1994	1
1995	4
1996	2
1997	3
1998	3
1999	1
2000	4
2001	10
2002	9
2003	9
2004	8
2005	5
2006	6
2007	7
2008	2
2009	8
2010	5
2011	4
2012	4
2013	8
2014	3
2015	1
2022	0

1

Mixed backbone antisense oligonucleotides: design, biochemical and biological properties of oligonucleotides containing 2'-5'-ribo- and 3'-5'-deoxyribonucleotide segments.

Kandimalla ER, Manning A, Zhao Q, Shaw DR, Byrn RA, Sasisekharan V, Agrawal S. Kandimalla ER, et al. Nucleic Acids Res. 1997 Jan 15;25(2):370-8. doi: 10.1093/nar/25.2.370. Nucleic Acids Res. 1997. PMID: 9016567 Free PMC article.

2

Single strand targeted triplex-formation. Destabilization of guanine quadruplex structures by foldback triplex-forming oligonucleotides.

Kandimalla ER, Agrawal S. Kandimalla ER, et al. Nucleic Acids Res. 1995 Mar 25;23(6):1068-74. doi: 10.1093/nar/23.6.1068. Nucleic Acids Res. 1995. PMID: 7537368 Free PMC article.

3

Antisense and/or immunostimulatory oligonucleotide therapeutics.

Agrawal S, Kandimalla ER. Agrawal S, et al. Among authors: kandimalla er. Curr Cancer Drug Targets. 2001 Nov;1(3):197-209. doi: 10.2174/1568009013334160. Curr Cancer Drug Targets. 2001. PMID: 12188879 Review.

4

Role of Toll-like receptors in antisense and siRNA [corrected].

Agrawal S, Kandimalla ER. Agrawal S, et al. Among authors: kandimalla er. Nat Biotechnol. 2004 Dec;22(12):1533-7. doi: 10.1038/nbt1042. Nat Biotechnol. 2004. PMID: 15583662 Review.

5

Synthetic agonists of Toll-like receptors 7, 8 and 9.

Agrawal S, Kandimalla ER. Agrawal S, et al. Among authors: kandimalla er. Biochem Soc Trans. 2007 Dec;35(Pt 6):1461-7. doi: 10.1042/BST0351461. Biochem Soc Trans. 2007. PMID: 18031246 Review.

6

Medicinal chemistry and therapeutic potential of CpG DNA.

Agrawal S, Kandimalla ER. Agrawal S, et al. Among authors: kandimalla er. Trends Mol Med. 2002 Mar;8(3):114-21. doi: 10.1016/s1471-4914(01)02264-x. Trends Mol Med. 2002. PMID: 11879771 Review.

7

Application of XIAP antisense to cancer and other proliferative disorders: development of AEG35156/ GEM640.

Lacasse EC, Kandimalla ER, Winocour P, Sullivan T, Agrawal S, Gillard JW, Durkin J. Lacasse EC, et al. Among authors: kandimalla er. Ann N Y Acad Sci. 2005 Nov;1058:215-34. doi: 10.1196/annals.1359.032. Ann N Y Acad Sci. 2005. PMID: 16394139 Review.

8

Antisense therapeutics: is it as simple as complementary base recognition?

Agrawal S, Kandimalla ER. Agrawal S, et al. Among authors: kandimalla er. Mol Med Today. 2000 Feb;6(2):72-81. doi: 10.1016/s1357-4310(99)01638-x. Mol Med Today. 2000. PMID: 10652480 Review.

9

Chemistry of CpG DNA.

Kandimalla ER, Agrawal S. Kandimalla ER, et al. Curr Protoc Nucleic Acid Chem. 2003 May;Chapter 4:Unit 4.16. doi: 10.1002/0471142700.nc0416s12. Curr Protoc Nucleic Acid Chem. 2003. PMID: 18428906

10

Modulation of Toll-like Receptor 9 Responses through Synthetic Immunostimulatory Motifs of DNA.

Agrawal S, Kandimalla ER. Agrawal S, et al. Among authors: kandimalla er. Ann N Y Acad Sci. 2003 Dec;1002:30-42. doi: 10.1196/annals.1281.005. Ann N Y Acad Sci. 2003. PMID: 14751820 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results